Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zoetis Inc (NYSE:ZTS)

53.97
Delayed Data
As of 4:01pm ET
 +0.47 / +0.88%
Today’s Change
38.26
Today|||52-Week Range
54.72
+0.82%
Year-to-Date
ZTS Regular Dividend: ZTS began trading ex-dividend on 01/18/17. A $0.105 dividend will be paid to shareholders of record as of 01/20/17.

Today’s Trading

Previous close53.50
Today’s open53.63
Day’s range53.60 - 54.39
Volume3,573,514
Average volume (3 months)3,351,976
Market cap$26.4B
Dividend yield0.78%
Data as of 4:01pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-41.38%
Earnings growth (this year)+9.73%
Earnings growth (next 5 years)+14.17%
Revenue growth (last year)-0.42%
P/E ratio38.8
Price/Sales5.05
Price/Book24.92

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...-0.34-0.73%
ALXNAlexion Pharmaceutic...-2.38-1.77%
INCYIncyte Corp-0.31-0.26%
VRTXVertex Pharmaceutica...+0.46+0.57%
Data as of 4:14pm ET, 01/20/2017

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)$0.45
Annual revenue (last year)$4.8B
Annual profit (last year)$339.0M
Net profit margin7.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
Florham Park, New Jersey

Forecasts


Search for Jobs